Adsorbent biprocessing clarification agents and methods of making and using the same

Information

  • Patent Grant
  • 10695744
  • Patent Number
    10,695,744
  • Date Filed
    Friday, June 3, 2016
    7 years ago
  • Date Issued
    Tuesday, June 30, 2020
    3 years ago
Abstract
Adsorbent clarification agents suitable for use in bioprocessing procedures are disclosed. Methods of making and using the adsorbent clarification agents are also disclosed.
Description
FIELD OF THE INVENTION

The present invention is directed to adsorbent clarification agents suitable for use in bioprocessing procedures. The present invention is further directed to methods of making and using adsorbent clarification agents for the removal of or separation of undesirable biological substances during bioprocessing procedures.


BACKGROUND

In recent years biopharmaceutical manufacturing has demonstrated major improvements in MAb production, exhibiting product titers as high as 25 g/L often associated with very high cell densities. High-density cell cultures with >150 million cells/mL pose a great challenge in further downstream processing because of a need to remove a large amount of biomass and increased levels of contaminants from cell debris generated during cell culture and harvesting. Production of biological substances (MAbs, in particular) usually involves processing a complex cell culture broth from which desired biological substances must be isolated and purified while maintaining high overall product recovery and quality. Traditionally, centrifugation and a combination of filtration techniques (tangential-flow filtration and depth filtration) have been widely accepted as workhorses for clarifying these complex cell culture broths. However, improvement of mammalian cell culture processes is providing for total cell densities far beyond traditional levels of 20×106 cells/mL for CHO cells to >150×106 cells/mL for PER.C6 cells. Thus, limitations of both centrifugation and filtration techniques are apparent by the high (≤40%) solids content of such harvests.


Centrifugation can be applied to process feed streams with high levels of solids, for instance. However, product recovery can be low because of increased pellet volumes and a need to desludge frequently (especially in large-scale continuous centrifugation). Additionally, cell disruption from shear forces generated during centrifugation can further decrease the efficiency of harvest clarification and potentially cause product damage and/or entrapment.


Depth filters are advantageous because they remove contaminants, and many come in single-use format, reducing the need for cleaning and validation. However, depth filters are currently unable to handle high-solids feedstreams and are often used in series with centrifugation. TFF can handle high solids loading, but this technique can exhibit poor yield because of polarization of solids at the membrane surface when processing highly dense feed streams. Excessive product dilution and cell lysis caused by shear forces can also limit the utility of TFF.


Flocculation of cell culture harvests has also been widely used to enhance clarification throughput and downstream filtration operations. Current techniques include the use of soluble polyionic polymers (such as DEAE dextran, acryl-based polymers, and polyethylene amine) and inorganic materials such as diatomaceous earth and perlites, which remove cells and cell debris. However, polymers must subsequently be removed from process streams, which requires monitoring and quantification by in-process and product-release assays. If IEX chromatography is included as a purification step in the downstream process, binding capacities will be greatly affected by the charged nature of flocculants. The high viscosity of polycation stock solutions presents an additional process challenge.


In recent years, various new clarification techniques have been developed. For example, (http://www.selectscience.net/product-news/sartorius-stedim-biotech) single use harvesting technology for high cell density cultures using diatomaceous earth (DE) as filter aid has been introduced. (Minow B., et al, BioProcess Int., Apr. 1, 2014). However, given its low surface area (BET˜1 m2/g) and non-porous nature, DE has no function in adsorption of proteins and/or other types of biologics, but only as filter aid.


In other processes, functionalized particulate materials have been used as adsorbents for clarification of cell broths. For example, WO2010043700 and WO2010043703 methods of clarification or removing host cell proteins by the utilization of anion exchange material in the process. The property or optimal conditions for the ion exchange materials are not described in the patent applications.


Efforts continue to further develop clarification materials and processes having improved agents in the form of functionalized particulate materials so as to improve binding capacity (i.e., the amount and the variety of biomaterials that can be bound to the adsorbent clarification agents) and/or binding selectivity of the functionalized particulate materials.


SUMMARY

The present invention addresses the need in the art for improved bioprocesses by the discovery that the use of certain functionalized porous inorganic oxide materials provide enhanced performance as clarification adsorbents. The adsorbents of the present invention unexpectedly provide exceptional binding capacity, as well as binding selectivity in bioprocesses (e.g., biopurification, bioseparation, etc.) when compared to known functionalized particulate materials.


In particular, the present invention provides improved bioprocesses employing polymeric functionalized inorganic oxide materials comprised of porous inorganic oxide particles having a sufficiently wide pore size distribution to enable the particles to capable of selectively bind to a wide variety of biomolecules including, but not limited to, cells, host cell proteins, nucleic acids, cell debris, chromatins, etc., so as to remove these materials during one or more bioprocessing steps. In some embodiments, the porous inorganic oxide particles have a pore size distribution as measured by a pore size distribution span 90 value of at least about 1.0. In other embodiments, wherein the porous particles having a pore size distribution as measured by a pore size distribution span 90 value of as much as about 5.0 to about 10.0.


Accordingly, the present invention is directed to polymer functionalized porous inorganic oxide particles having a specified pore size distribution (also referred to herein as “adsorbents”) which are useful as clarification agents in a variety of bioprocesses. In one exemplary embodiment, the present invention is directed to adsorbents comprising polymeric material covalently bonded to the surface of porous inorganic oxide particles wherein said particles have a pore size distribution as measured by a pore size distribution span 90 value of at least about 1.0. In some desired embodiments, the invention comprise the adsorbents useful as a bioprocessing clarification agent, wherein the adsorbents comprise a polyelectrolyte material covalently bonded to the surface of porous inorganic oxide particles, wherein the porous particles having a pore size distribution as measured by a pore size distribution span 90 value of as much as about 5.0 to about 10.0. In preferred embodiments of the invention, the polymeric material comprises a polyelectrolyte, e.g. polyethyleneimine. In an even more preferred embodiment of the invention, the porous metal oxide particle comprise silica.


The present invention is even further directed to methods of making adsorbents in the form of functionalized particulate material. In one exemplary embodiment, the method of making adsorbents of the present invention comprises: contacting porous inorganic metal oxide particles with one or more reactants under reaction conditions that result in at least one polymeric material covalently bonded to at least one surface of the metal oxide particles, wherein the metal oxide particles have a wide pore size distribution as measured by a pore size distribution span 90 value of at least about 1.0.


The present invention is also directed to a method for the clarification of a bioprocess mixture during a bioprocessing procedure. The method provides for the removal or separation of the undesirable biological substances, e.g. cell debris, from a bioprocessing mixture by using the absorbents of the invention.


These and other features and advantages of the present invention will become apparent after a review of the following detailed description of the disclosed embodiments and the appended claims.





BRIEF DESCRIPTION OF THE DRAWINGS

FIGURE graphically shows the comparison in pore size distributions (from mercury porosimetry) for two different silicas.





DETAILED DESCRIPTION

To promote an understanding of the principles of the present invention, descriptions of specific embodiments of the invention follow and specific language is used to describe the specific embodiments. It will nevertheless be understood that no limitation of the scope of the invention is intended by the use of specific language. Alterations, further modifications, and such further applications of the principles of the present invention discussed are contemplated as would normally occur to one ordinarily skilled in the art to which the invention pertains.


It must be noted that as used herein and in the appended claims, the singular forms “a”, “and”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “an oxide” includes a plurality of such oxides and reference to “oxide” includes reference to one or more oxides and equivalents thereof known to those skilled in the art, and so forth.


“About” modifying, for example, the quantity of an ingredient in a composition, concentrations, volumes, process temperatures, process times, recoveries or yields, flow rates, and like values, and ranges thereof, employed in describing the embodiments of the disclosure, refers to variation in the numerical quantity that may occur, for example, through typical measuring and handling procedures; through inadvertent error in these procedures; through differences in the ingredients used to carry out the methods; and like proximate considerations. The term “about” also encompasses amounts that differ due to aging of a formulation with a particular initial concentration or mixture, and amounts that differ due to mixing or processing a formulation with a particular initial concentration or mixture. Whether modified by the term “about” the claims appended hereto include equivalents to these quantities.


As used herein, the terms “bioprocess” or bioprocessing” refer to a batch process that forms, alters and/or utilizes one or more biomolecules. The term “bioprocess” includes, but is not limited to, bioseparation processes, biopurification processes, processes for forming biopharmaceuticals, and processes for purifying biopharmaceuticals. As used herein, the term “bioprocess” or bioprocessing” refers to processing that may take place prior to a chromatography process (e.g., removing cell debris from a batch of material), does not encompass chromatography processes (e.g., liquid chromatography).


As used herein, the term “biomolecule” means any molecule that is produced by a living organism, including large molecules such as proteins, polysaccharides, lipids, and nucleic acids; and small molecules such a primary metabolites, secondary metabolites, and natural products. Examples of biomolecules include cells and cell debris; antibodies, proteins and peptides; nucleic acids, such as DNA and RNA; endotoxins; viruses; vaccines and the like. Other examples of biomolecules include those recited in WO 2002/074791 and U.S. Pat. No. 5,451,660.


As used herein, “porous inorganic metal oxide particles” includes particles comprised of inorganic metal oxide materials having intra-particle pores or inter-particle pores in cases where smaller particles are agglomerated to form larger particles Inorganic metal oxides include, but is not limited to, silica, alumina, zirconia or the combination of them.


As used herein, the term “functionalized” as it relates to the surface of the inorganic oxide particles means porous inorganic metal particles that have been surface modified by reaction with at least one functional compound to alter the selectivity of at least a portion of the particle surface, including the surface area on the external portion of the particles, and/or on the surface area of the internal pores. The functionalized surface of the particles may be used to form a bonded phase (covalently or ionically), a coated surface (e.g., reverse phase C18 bonded), a polymerized surface (e.g., ion exchange), an inherent surface (e.g., inorganic/organic hybrid material), or the like. For example, reacting porous inorganic oxide particles with octadecyltrichlorosilane forms a “reverse phase” by covalently bonding the silane to the inorganic surface (e.g., C4, C8, C18, etc.). In another example, reaction of the inorganic particles with aminopropyltrimethoxysilane followed by quaternization of the amino group forms an “anion exchange phase.” In a third example, a bonded phase may be formed by reaction of the inorganic particles with aminopropyltrimethoxysilane followed by formation of an amide with an acid chloride. Other bonded phases include diol, cyano, cation, affinity, chiral, amino, C18, hydrophilic interaction (HILIC), hydrophobic interaction (HIC), mixed mode, size exclusion, etc. As part of the bonded phase or functionalized surface, a ligand may be used to show specific interaction with the target molecule or biomolecule (e.g., ligate), such as those set forth in U.S. Pat. No. 4,895,806.


As used herein, the term “polyelectrolyte” is defined as meaning a polymer comprising repeating units such as (i) a cation, (ii) an anion, or (iii) an electrolyte functional group that associates or dissociates with a proton in aqueous solutions to form a positive or negative charge. For example, cationic polyelectrolytes suitable for use in the present invention include, but are not limited to, polyethyleneimine (PEI), polyallylamine, polyvinyl pyridine, polydiallyldimethylammonium chloride (pDADMAC), and copolymers containing similar functional groups. Anionic polyelectrolytes suitable for use in the present invention include, but are not limited to, polyacrylic acids, polymethacrylic acids, polystyrene sulfonic acids, nucleic acids, and copolymers containing similar functional groups (e.g., poly(styrene-co-maleic acid, poly(styrene sulfonic acid-co-maleic acid))


As used herein, the term “polyethyleneimine” is defined as meaning a polymer comprising repeating units of an amine bonded to a —CH2CH2— spacer, wherein the polymer may be linear or branched and may contain primary, secondary and/or tertiary amino groups.


As used herein, the term “BET particle surface area” is defined as meaning a particle surface area as measured by the Brunauer Emmet Teller nitrogen adsorption method.


As used herein, the term median pore diameter (size) distributions were measured by mercury intrusion using an Autopore® IV 9520, available from Micromeritics Instrument Corporation (Norcross, Ga.).


As used herein, the term “pore size distribution” means the relative abundance of each pore size in a representative volume of porous inorganic particles.


As used herein “median pore diameter” is the Median pore diameter (PD50) is defined as the midpoint at which 50% of the pore volume is contributed by smaller pores and 50% is contributed by larger pores.


As used herein, the term “pore volumes” referenced herein represent cumulative volumes from mercury intrusion into 50-10,000 Å size pores.


As used herein, the term “molecular weight” is defined as meaning the molar mass of a single molecule of a particular compound or polymer.


As used herein, the “pore size distribution span 90 value” is calculated as [(PD90−PD10)/PD50], whereas PD10 is the pore diameter at 10% cumulative pore volume contribution, PD50 is the pore diameter at 50% cumulative pore volume contribution, and PD90 is the pore diameter at 90% cumulative pore volume contribution, all based on mercury intrusion data.


Porous Particles


As discussed above, the porous inorganic metal oxide particles useful to prepare the adsorbents of the present invention possess a wide pore size distribution as measured by a pore size distribution span 90 value of at least about 1.0 (or at least about 2.0, or at least about 3.0, or at least about 4.0, or at least about 5.0, or at least about 6.0, or at least about 7.5, desirably, from about 5.0 to about 10.0, more desirably, from about 7.5 to about 8.5, and in some embodiments, about 7.8). The wide pore size distribution enables the formation of adsorbent clarification agents that provide exceptional binding capacity, binding selectivity, as well as binding of a wide variety of biomolecules.


Generally, the porous inorganic metal oxide particles have a pore size distribution of from about 30 to about 5000 Å.


Advantageously, the wide pore size distribution of the porous inorganic metal oxide particles used to form the adsorbents of the present invention enables controlled binding capacity, binding selectivity, and binding of a wide variety of biomolecules by choosing (1) specific polymeric material bound to surfaces of the metal oxide particles, (2) the amount of polymeric material bound to surfaces of the metal oxide particles, and/or (3) the molecular weight of the polymeric material bound to surfaces of the metal oxide particles. As shown and discussed in the example section below, the wide pore size distribution of the metal oxide particles used to form the adsorbents of the present invention provides more flexibility and binding capacity when compared to known, commercially available adsorbents.


Typically, the porous metal oxide particles useful to prepare the adsorbents of the invention possess a median pore size of at least about 100 Å. In another embodiment, the porous inorganic particles have a median pore size of at least about 150 Å (or at least about 200 Å; or at least about 250, or at least about 300 Å; or at least about 350 Å; or at least about 400 Å, or at least about 500 Å; or at least about 600 Å; or at least about 800 Å. In some embodiments, the porous inorganic particles have a median pore size of from about 100 Å to about 800 Å. In some embodiments, the porous inorganic particles have a median pore size of from about 150 Å to about 250 Å. In other embodiments, the porous inorganic particles have a median pore size of less than 2000 Å. In other embodiments, the porous inorganic particles have a median pore size of less than 1000 Å.


The metal oxide particles typically have a particle size, as measured by a median particle dimension, of less than 150 μm. The porous inorganic metal oxide particles typically have a median particle dimension of about 1 μm, more typically, less than about 100 μm. In some embodiments, the porous inorganic particles have a median particle dimension of from about 10 to about 50 μm, more desirably, about 30 μm.


Typically, the metal oxide particles typically have an irregular shape, but may have any shape (e.g., spherical, elliptical, etc.). Regardless of shape, the porous inorganic metal oxide particles typically have a median particle dimension as discussed hereinabove.


In additional embodiments, the porous inorganic metal oxide particles may have an aspect ratio of at least about 1.0 as measured, for example, using Transmission Electron Microscopy (TEM) techniques. As used herein, the term “aspect ratio” is used to describe the ratio between (i) the median particle dimension of the porous inorganic particles and (ii) the median cross-sectional particle dimension of the porous inorganic particles, wherein the cross-sectional particle dimension is substantially perpendicular to the largest particle dimension of the porous inorganic particles. In some embodiments of the present invention, the porous inorganic particles have an aspect ratio of at least about 1.1 (or at least about 1.2, or at least about 1.3, or at least about 1.4). Typically, the porous inorganic particles have an aspect ratio of from about 1.0 to about 1.5.


The pore volume of the porous inorganic metal oxide particles as measured by mercury intrusion into 50-10,000 Å size pores is at least about 0.25 cc/g. In another embodiment, the pore volume of the porous inorganic metal oxide particles as measured by mercury intrusion into 50-10,000 Å size pores is at least 0.50 cc/g. In one exemplary embodiment of the present invention, the porous inorganic particles have a pore volume as measured by mercury intrusion into 50-10,000 Å size pores is at least about 1.0 cc/g; at least about 1.50 or at least about 1.77 cc/g. In another exemplary embodiment of the present invention, the porous inorganic particles have a pore volume as measured by mercury intrusion into 50-10,000 Å size pores of from about 1.0 cc/g to about 3.0 cc/g.


The surface area of porous inorganic metal oxide particles also have a surface area as measured by the BET nitrogen adsorption method (i.e., the Brunauer Emmet Teller method) of at least about 100 m2/g, or at least about 300 m2/g, or at least about 500 m2/g. In one exemplary embodiment of the present invention, the porous inorganic oxide particles have a BET surface area of from about 100 m2/g to about 1000 m2/g, or from 600 m2/g to about 800 m2/g. In a further exemplary embodiment of the present invention, the porous inorganic oxide particles have a BET surface area of from about 700 m2/g.


The porous inorganic metal oxide particles useful to prepare the adsorbents of the invention may comprise a variety of inorganic materials including, but not limited to, silica, alumina, zirconia, or mixtures thereof. In one desired embodiment, the metal oxide particles comprise silica. When the metal oxide particles comprise silica, the particles desirably comprise silica having a purity of at least about 93% by weight SiO2, or at least about 93% by weight SiO2, at least about 94% by weight SiO2, at least about 95% by weight SiO2, at least about 96% by weight SiO2, at least about 97% by weight SiO2, or at least about 98% by weight SiO2 up to 100% by weight SiO2 based upon the total weight of the particle.


Adsorbents


In accordance with the present invention, the absorbent comprises porous metal oxide particles as described herein above and a polymeric material covalently bonded to surfaces of said metal oxide particles. In one embodiment the adsorbents comprises at least one bifunctional moiety extending from said surfaces of said metal oxide particles, each of said at least one bifunctional moiety comprising (i) one or more functional groups capable of bonding to said surfaces, and either (iia) said polymeric material, or (iib) one or more reactive groups capable of bonding to said polymeric material.


In another embodiment, the adsorbents comprises at least one bifunctional moiety extending from the surfaces of said metal oxide particles, each of said at least one bifunctional moiety comprising (i) one or more functional groups capable of bonding to said surfaces, and (iia) said polymeric material.


In yet another embodiment, the adsorbents comprises at least one bifunctional moiety extending from said surfaces of said metal oxide particles, each of said at least one bifunctional moiety comprising (i) one or more functional groups capable of bonding to said surfaces, and (iib) one or more reactive groups capable of bonding to said polymeric material.


Suitable bifunctional moiety extending from the surface of said metal oxide particle comprises epoxy rings that can react with amine groups from the polymer chains of the polyelectrolytes. In one embodiment, the at least one bifunctional moiety comprising the adsorbent comprises product from reaction of metal oxide surface with an epoxy silane. In a preferred embodiment, the epoxy siliane comprises (3-glycidoxypropyl)-trimethoxysilane.


In one embodiment of the invention, the polymeric material is covalently bonded to the surface of the metal oxide particles via a covalent bond linkage consisting of one or more atoms selected from the group consisting of C, O, Si and N.


Typically, the polymeric material comprises a polyelectrolyte. The polyelectrolyte may be cationic or anionic. Suitable cationic polyelectrolyte materials comprise polyethyleneimine, polyallylamine, polyvinyl pyridine, polydiallyldimethylammonium chloride (pDADMAC), a copolymer containing one or more cationic or cationic-forming functional groups, or combinations thereof. The cationic polyelectrolyte may also comprises a reaction product of said metal oxide particles and an aqueous trimethoxysilyl-polyethyleneimine solution. In a preferred embodiment, the polymeric material comprises polyethyleneimine. In even more preferred embodiment, the polyethyleneimine have (i) a weight average molecular weight, Mw, and (ii) a number average molecular weight, Mn, each of which is less than about 5000. In still a more preferred embodiment, the polyethyleneimine has (i) a weight average molecular weight, Mw, and (ii) a number average molecular weight, Mn, each of which ranges from about 500 to about 2500; or. (i) a weight average molecular weight, Mw, ranging from about 800 to about 2000, and (ii) a number average molecular weight, Mn, ranging from about 600 to about 1800.


In one embodiment, the polymeric material comprise a polyethyleneimine has a structure:




embedded image



prior to being covalently bonded to said surfaces, and n is a number greater than or equal to 1.


Suitable anionic polyelectrolyte materials comprises polyacrylic acid, polymethacrylic acid, polystyrene sulfonic acid, nucleic acid, a copolymer containing one or more anionic or anionic-forming functional groups or combinations thereof. In a preferred embodiment, the anionic polyelectrolyte material comprises polyacrylic acid, polymethacrylic acid, or a combination thereof. In a more preferred embodiment, the anionic polyelectrolyte material comprise a polyacrylic acid or a polymethacrylic acid having a weight average molecular weight, Mw, greater than about 50,000. In an even more preferred embodiment, the polyacrylic acid or polymethacrylic acid has a weight average molecular weight, Mw, of from about 100,000 to about 250,000.


The amount of the polymeric material present in the absorbent is any amount suitable to provide charge interactions with biologics and therefore selectively bind to these biologics of opposite charge. In one embodiment, the polymeric materials comprise an amount such that less than 100% of said surfaces of the metal oxide particles are bonded to said polymeric material. In another embodiment, said the polymeric material is present on the adsorbent in an amount representing up to about 20.0 wt % of said adsorbents based on a total weight of said adsorbents. In other embodiments, the polymeric material is present in an amount representing from about 1.0 to about 15.0 wt % of said adsorbents based on a total weight of said adsorbents.


In a preferred embodiment of the invention, the porous metal oxide particles comprising the adsorbents comprise silica particles.


Methods of Making Adsorbents


The absorbent of the invention are generally prepare contacting the metal oxide particles with one or more reactants under reaction conditions that result in covalently bonding the polymeric material to the surfaces of the metal oxide particles. The contacting step may utilize a solvent. In one embodiment, the contacting step utilizes a reaction mixture free of organic solvent.


In one embodiment of the invention, the one or more reactants comprise at least one bifunctional compound comprising (i) one or more functional groups capable of bonding the compound to the surfaces of the metal oxide particles, and either (iia) the polymeric material, or (iib) one or more reactive groups capable of bonding to the polymeric material.


Suitable reactants comprising least one bifunctional compound comprising (i) one or more functional groups capable of bonding the compound to the surfaces of the metal oxide particles, and (iia) the polymeric material include, but is not limited to, polyethyleneimines.


Suitable reactants comprising at least one bifunctional compound comprising (i) one or more functional groups capable of bonding the compound to the surfaces of the metal oxide particles, and (iib) one or more reactive groups capable of bonding to the polymeric material, include but is not limited to, polyacrylic acids.


It is also within the scope of the invention to choose the one or more reactants so as to produce adsorbents having a desired degree of affinity for one or more particular biological compounds through attraction due to opposite charges. For example, the affinity of negatively charged DNA towards positively charges surface. The amount of each of the one or more reactants may also be chosen so as to form adsorbents having a desired degree of particle surface coverage by the polymeric material.


Use of Adsorbents


Adsorbent in accordance with the present invention comprise porous inorganic metal oxides surface functionalized with polyelectrolytes. To achieve the adsorption of higher amount of undesirable biological substances, the requirements of the porous molecules are high pore volume (>1.0 cc/g) and high pore size distribution span 90 value (>1.0). If these conditions are met, with the bonding of polyelectrolyte, either positively or negatively charged, the adsorbent materials can be effectively used for use as both adsorbents and clarification agents. In one embodiment, the functionalize adsorbents are used as a bioprocessing clarification agent, wherein the adsorbents comprises: metal oxide particles having a wide pore size distribution as measured by a pore size distribution span 90 value of at least about 1.0; and polymeric material covalently bonded to surfaces of the metal oxide particles.


The absorbent may be used by contacting the functionalized porous adsorbent in a bioprocessing vessel containing undesirable biologics obtained during a bioprocessing procedure; allowing a sufficient incubation time to permit adsorption of the undesirable biologics to the adsorbent or formation of cell pellet and a supernatant layer; separating the resulting mixture through either filtration or decanting or pumping out the supernatant layer and thereafter extracting the desired biological substance from either the filtrates or supernatant or carrying out further purification steps including depth filtration and downstream chromatography steps.


In one embodiment, the adsorbents in accordance with the present invention are added to a bioprocessing vessel containing one or more biomolecules selected from the group consisting of a protein, a polysaccharide, a lipid, a nucleic acid, a metabolites, a mammalian cell, mammalian cell debris, an antibody, a peptide, DNA, RNA, an endotoxin, a virus, a vaccine, an enzyme, or any combination thereof. In other embodiment, the bioprocessing vessel contain at least one of: host cells, cell debris, host cell proteins, nucleic acids, chromatins, antibodies, virus, or vaccines. The functionalized adsorbents bind to one or more biomolecules that come into contact with the adsorbents. Following the binding step in which the adsorbents binds to one or more biomolecules that come into contact with the adsorbents, the adsorbents bound to the one or more biomolecules is separated from other components of the bioprocessing procedure.


It should be understood that although the above-described adsorbents and methods are described as “comprising” one or more components or steps, the above-described adsorbents and methods may “comprise,” “consists of,” or “consist essentially of” any of the above-described components or steps of the adsorbents and methods. Consequently, where the present invention, or a portion thereof, has been described with an open-ended term such as “comprising,” it should be readily understood that (unless otherwise stated) the description of the present invention, or the portion thereof, should also be interpreted to describe the present invention, or a portion thereof, using the terms “consisting essentially of” or “consisting of” or variations thereof as discussed below.


As used herein, the terms “comprises,” “comprising,” “includes,” “including,” “has,” “having,” “contains”, “containing,” “characterized by” or any other variation thereof, are intended to encompass a non-exclusive inclusion, subject to any limitation explicitly indicated otherwise, of the recited components. For example, an adsorbent and/or method that “comprises” a list of elements (e.g., components or steps) is not necessarily limited to only those elements (or components or steps), but may include other elements (or components or steps) not expressly listed or inherent to the adsorbent and/or method.


As used herein, the transitional phrases “consists of” and “consisting of” exclude any element, step, or component not specified. For example, “consists of” or “consisting of” used in a claim would limit the claim to the components, materials or steps specifically recited in the claim except for impurities ordinarily associated therewith (i.e., impurities within a given component). When the phrase “consists of” or “consisting of” appears in a clause of the body of a claim, rather than immediately following the preamble, the phrase “consists of” or “consisting of” limits only the elements (or components or steps) set forth in that clause; other elements (or components) are not excluded from the claim as a whole.


As used herein, the transitional phrases “consists essentially of” and “consisting essentially of” are used to define a adsorbents and/or method that includes materials, steps, features, components, or elements, in addition to those literally disclosed, provided that these additional materials, steps, features, components, or elements do not materially affect the basic and novel characteristic(s) of the claimed invention. The term “consisting essentially of” occupies a middle ground between “comprising” and “consisting of”.


Further, it should be understood that the herein-described adsorbents and/or methods may comprise, consist essentially of, or consist of any of the herein-described components and features, as shown in the figures with or without any feature(s) not shown in the figures. In other words, in some embodiments, the adsorbents and/or methods of the present invention do not have any additional features other than those shown in the figures, and such additional features, not shown in the figures, are specifically excluded from the adsorbents and/or methods. In other embodiments, the adsorbents and/or methods of the present invention do have one or more additional features that are not shown in the figures.


The present invention is further illustrated by the following examples, which are not to be construed in any way as imposing limitations upon the scope thereof. On the contrary, it is to be clearly understood that resort may be had to various other embodiments, modifications, and equivalents thereof which, after reading the description herein, may suggest themselves to those skilled in the art without departing from the spirit of the present invention and/or the scope of the appended claims.


EXAMPLES

Median particle sizes were determined by laser light scattering using a Malvern Mastersizer 2000, available from Malvern Instrument Ltd. (per ASTM B822-10). Particle size is defined as median particle size by volume distribution. BET surface areas were obtained from the nitrogen sorption analysis described in the literature. Median pore size, pore volume and pore size distribution were calculated based on mercury intrusion into 35-10000 Å size pores. Pore volume is defined as cumulative pore volume in the same pore size range, and median pore size is determined a pore diameter (size) at which 50% pore volume is contributed from smaller pores and 50% pore volume is contributed from bigger pores. Span 90 is defined as a relative pore size span and calculated as (PD90−PD10)/PD50, whereas PD10 is pore diameter at 10% cumulative pore volume contribution and PD50 and PD90 is as defined as 50% and 90% cumulative pore volume contributions based on mercury data, respectively.


1. Polyethyleneimine (PEI) Bonding for Cationic Surface


Six different grades of silica (A, B, C, D, E, F), available from W. R. Grace, were used in the these examples, and their properties (BET Surface Area, Pore Volume, Pore size distribution Span 90, and median pore size PD50) are listed in the Table I below:













TABLE I






Surface Area
Pore Volume

PD50


Silica
(m2/g)
(cc/g)
Span 90
(Å)



















A
699
1.77
7.80
432


B
253
1.19
2.80
154


C
79
1.21
1.25
500


D
711
0.10
0.94
90


E
314
0.57
1.10
569


F
713
0.58
0.93
104


G
247
0.18
0.43
50


H
1
0
0
0









The particle size of these silica ranges from 5 μm to 70 μm. Silica B is commercial silica with a Trade name of Syloid® W900, Silica C is a commercial silica with a Trade name of Davisil® XWP 500, Silica F is a commercial silica with a Trade name of Trisyl®. All these are available from W. R. Grace & Co. Silica G is a commercially available (Polyethyleneimine on silica gel, powder, 40-200 mesh from Sigma-Aldrich Corporation) PEI bonded silica sample. Silica H in the Table is a diatomaceous earth (powder, suitable for most filtrations, from Sigma-Aldrich Corporation) and the bonding with PEHA was attempted using the same procedure as the other samples.


Silica A, B had the properties of Pore Volumes of greater than 1.0 cc/g and Span 90 values of greater than 1.0.


In the examples, pentaethylenehexamine (PEHA) was used, a mixture of small molecule polyamines to represent PEI in our examples.


The bonding process consisted of two steps: 1). Surface bonding with epoxy silane (3-glycidoxypropyl-trimethoxysilane), and then 2). Reaction of PEHA with surface epoxy groups (attacking of nucleophilic amino groups to the epoxy ring, and this leads to amine attachment with opening of epoxy ring, forming β-amino alcohols (N. Azizi, M. R. Saidi, Org. Lett., 2005, 7, 3649-3651).


1A. Initial Bonding Procedure


Modified silica samples were prepared by treating the bare silica gel particles (dried in a 120.0° C. oven overnight) with epoxy silane. A 1 L, round bottom indented flask was charged with silica particles (100 g), and then 10 g (10 w/w % to silica) of epoxy silane is added drop-wise into the flask while rotating. The mixture was allowed to roll on a rotovap overnight (16 h). A small portion (2 g) of the sample was separated and washed with 10 ml of acetone five times and dried in a 70° C. oven for 20 hours. The dried sample was subjected to elemental analysis for the amount of carbon content by using a LECO instrument.


1B. PEI Reaction


20 g of bonded silica was weighed from the sample obtained in 1A above and placed in an Erlenmeyer Flask. 6 g of PEHA was weighed in a small beaker (30% w/w to silica), and mixed with 100 g of DIW to dissolve PEHA, to provide ˜15% silica slurry for the reaction). The mixture was shaken well and allowed to sit in a water bath (65° C. for 30 min). After the reaction, the silica was further diluted with DI water, filter. Then the silica was soaked with 50 ml 0.5 M HCl for 20-30 minutes and filtered. The resulting silica was washed with DIW for three times (3×100 ml) and dried a small sample at 90° C. overnight. The dried sample was sent for C % analysis. The rest of sample was dried inside the hood in ambient conditions prior to analysis.


1C. Batch Binding Capacity Test


Two model compounds were used in these examples: 1. DNA oligonucleotides (Deoxyribonucleic acid from herring sperm from Sigma-Aldrich), less than 50 base pairs, MW<15000. 2. Bovine serum albumin (BSA) (lyophilized powder, crystallized, ≥98.0% From Sigma), MW ˜66000.


Test method: The binding capacities were performed using BSA solution (5 mg/ml) at a pH of 8.0 with 20 mM Tris-HCl buffer, or DNA solution (2 mg/ml) at pH 3.45 with 10 mM sodium phosphate buffer. Dried silica samples were weighed into vials, and then protein solutions (UV/Vis adsorption was measured at 280 nm using a Genesys®10S Bio UV-Vis spectrophotometer). After 2 hr, the supernatants were collected the adsorptions were again measured under the same conditions. The percentage of UV/Vis signal drop were calculated (the higher drop before and after the adsorption, the greater binding capacity). Three parallel adsorption measurements were carried out for one sample and the averages were calculated and reported.


The following table shows the binding capacity results of Examples 1-10:













TABLE 2








DNA
BSA


Examples
Silica
C %
Binding
Binding



















1
A
3.19
94%
 33%


2
B
1.70
77%
 41%


3
C
1.25
37%
 23%


4
D
4.17
89%
0.1%


5
E
0.92
38%
5.6%


7
F
4.06
61%
1.1%


8
G
8.07
8.4% 
0.0%


9
H
0.05
2.0% 
0.0%


10
A
Unmodified
20%
4.1%









As mentioned above, Examples 1-6 were made by treating the dried silica with epoxysilane and then followed by reacting the silica intermediates with PEHA. The C % numbers, calculated by subtracting the total C % from the C % from the epoxy bonded silica, are indications of the total amount of amines are attached from the reactions. For Sample 7 (commercial PEI-silica) (BET and Hg measurements were carried out after the surface groups of the sample were burnt off by placing samples in an 460° C. muffler oven in air overnight) the binding of DNA and BSA were measured using the same measurement method. The diatomaceous earth (Silica H) for Example 8 was also bonded with PEHA using the same procedure. As shown, Example 8 has very low level of amount of PEHA bonded (due to very low surface area) and the amount of DNA adsorbed.


The results shown above indicate that in order to get high amount of DNA and BSA adsorbed, high pore volume and span 90 are required. Samples 1, 2, and 3 had both pore volume and Span 90 greater than 1.0, and these samples have showed higher binding of both DNA and BSA. Other samples all showed lower binding. In Example 9, due to its high surface area, unbounded silica A had some binding capability of DNA and BAS, but the binding were very low when compared to PEHA bonded Sample 1.


The FIGURE shows the comparison in pore size distributions (from mercury porosimetry) for Silica A and Silica G. As noted, Silica A has the widest pores size distribution ranging from 50 Å to over 5000 Å.


2. Bonding Silica with Anionic Polymers for Binding of Basic Proteins


2A. Preparation


The preparation of anionic polymer bonded silica was achieved by mixing the neutral aqueous solution of polymers (neutralized by base such as ammonium hydroxide or sodium hydroxide) with silica, and then baking the mixture at 190° C. for 5 hrs to force the bonding formation of the polymer and the surface groups. The solutions of commercial poly(acrylic acid) or poly(methacrylic acid) (from Sigma-Aldrich Corporation) were made by dissolving (or diluting if commercial product is an aqueous solution) polymer in DI water and the pH of the solution is adjusted to 7-8 with ammonium hydroxide (or sodium hydroxide). The concentration for the solutions was about 18%.


20 g of silica (Silica A) was mixed with polymer solution containing about 10 g of net polymer. The mixture was placed in a ceramic container and place in an oven in a well ventilated fume hood. The mixture was heated at 90° C. until no liquid is seen, and then baked at 190° C. for 5 hrs. The resulting mixture was re-slurried with DI water, and washed with 5×200 ml of 10% NaCl and 1×200 ml of NaHCO3, followed by 3×100 ml DI water.


2B. Protein Binding Evaluation


The procedure was similar to procedure as described in 1C, with exception that lysozyme (from chicken egg white, lyophilized powder, protein ≥90%, ≥40,000 units/mg protein from Sigma) was used in this test, and the concentration of the protein was 25 mg/ml in 50 mM sodium phosphate, pH 7.0. The amount of adsorbed protein was measured through the amount of signal loss after 2 hr incubation at room temperature, from UV/Vis at 280 nm wavelength, and calculated by lysozyme absorption coefficient.


The following Table 3 shows the protein binding results for Examples 11-14 below:













TABLE 3









Lysozyme




Polymer

Binding


Example #
Polymer
MW
C %
(mg/mg)



















10
PAA
100000
18.24
1.44


11
PAA
240000
20.55
1.44


12
PAA
15000
5.05
0.67


13
PMA
9500
0.50
0.45


14
None
None
0.00
0.52



(Control)









Table 3 shows that higher lysozyme binding is associated with high molecular weight of polymer. Low molecular weight polymer samples had similar binding to that of control, non-polymer bonded silica (Sample 14).


While the invention has been described with a limited number of embodiments, these specific embodiments are not intended to limit the scope of the invention as otherwise described and claimed herein. It may be evident to those of ordinary skill in the art upon review of the exemplary embodiments herein that further modifications, equivalents, and variations are possible. All parts and percentages in the examples, as well as in the remainder of the specification, are by weight unless otherwise specified. Further, any range of numbers recited in the specification or claims, such as that representing a particular set of properties, units of measure, conditions, physical states or percentages, is intended to literally incorporate expressly herein by reference or otherwise, any number falling within such range, including any subset of numbers within any range so recited. For example, whenever a numerical range with a lower limit, RL, and an upper limit RU, is disclosed, any number R falling within the range is specifically disclosed. In particular, the following numbers R within the range are specifically disclosed: R=RL+k(RU−RL), where k is a variable ranging from 1% to 100% with a 1% increment, e.g., k is 1%, 2%, 3%, 4%, 5% . . . 50%, 51%, 52% . . . 95%, 96%, 97%, 98%, 99%, or 100%. Moreover, any numerical range represented by any two values of R, as calculated above is also specifically disclosed. Any modifications of the invention, in addition to those shown and described herein, will become apparent to those skilled in the art from the foregoing description and accompanying drawings. Such modifications are intended to fall within the scope of the appended claims. All publications cited herein are incorporated by reference in their entirety.

Claims
  • 1. Adsorbents for use as a bioprocessing clarification agent, said adsorbents comprising: metal oxide particles having a wide pore size distribution as measured by a pore size distribution span 90 value of greater than 2.5; andpolymeric material covalently bonded to surfaces of said metal oxide particles.
  • 2. The adsorbents of claim 1, wherein said metal oxide particles have a median particle size of less than about 150 μm.
  • 3. The adsorbents of claim 2, wherein said metal oxide particles have a median pore size of less than about 2000 Å.
  • 4. The adsorbents of claim 3, wherein said metal oxide particles have a pore size distribution of from about 30 to about 5000 Å.
  • 5. The adsorbents of claim 1, wherein said metal oxide particles have a BET particle surface area of at least about 100 m2/g up to about 1000 m2/g.
  • 6. The adsorbents of claim 1, wherein said metal oxide particles have a pore volume, as measured by mercury intrusion, of from about 1.0 ml/g up to about 2.0 ml/g.
  • 7. The adsorbents of claim 1, wherein said metal oxide particles have a pore size distribution span 90 value of about 2.8 to about 7.8.
  • 8. The adsorbents of claim 1, further comprising at least one bifunctional moiety extending from said surfaces of said metal oxide particles, each of said at least one bifunctional moiety comprising (i) one or more functional groups capable of bonding to said surfaces, and either (iia) said polymeric material, or (iib) one or more reactive groups capable of bonding to said polymeric material.
  • 9. The adsorbents of claim 8, wherein said at least one bifunctional moiety comprises an epoxy silane.
  • 10. The adsorbents of claim 9, wherein said at least one bifunctional moiety comprises (3-glycidoxypropyl)-trimethoxysilane.
  • 11. The adsorbents of claim 1, wherein said polymeric material is covalently bonded to said surfaces via a covalent bond linkage consisting of one or more atoms selected from the group consisting of C, O, Si and N.
  • 12. The adsorbents of claim 1, wherein said polymeric material comprises a cationic polyelectrolyte.
  • 13. The adsorbents of claim 12, wherein said cationic polyelectrolyte comprises polyethyleneimine, polyallylamine, polyvinyl pyridine, polydiallyldimethylammonium chloride (pDADMAC), or a copolymer containing one or more cationic or cationic-forming functional groups or the reaction product of said metal oxide particles and an aqueous trimethoxysilyl-polyethyleneimine solution.
  • 14. The adsorbents of claim 13, wherein said cationic polyelectrolyte comprises polyethyleneimine having (i) a weight average molecular weight, Mw, and (ii) a number average molecular weight, Mn, each of which is less than about 5000.
  • 15. The adsorbents of claim 13, wherein said cationic polyelectrolyte comprises polyethyleneimine having a structure:
  • 16. The adsorbents of claim 1, wherein said polymeric material comprises an anionic polyelectrolyte.
  • 17. The adsorbents of claim 16, wherein the anionic polyelectrolyte comprises polyacrylic acid, polymethacrylic acid, polystyrene sulfonic acid, nucleic acid, or a copolymer containing one or more anionic or anionic-forming functional groups.
  • 18. The adsorbents of claim 1, wherein said polymeric material is present in an amount representing up to about 20.0 wt % of said adsorbents based on a total weight of said adsorbents.
  • 19. The adsorbents of claim 1, wherein less than 100% of said surfaces are bonded to said polymeric material.
  • 20. The adsorbents of claim 1, wherein said metal oxide particles comprise silica particles.
  • 21. The adsorbents of claim 1, wherein the adsorbents are bound to one or more particular biological compounds, wherein the one or more particular biological compounds comprise a protein, a polysaccharide, a lipid, a nucleic acid, a metabolites, a mammalian cell, mammalian cell debris, an antibody, a peptide, DNA, RNA, an endotoxin, a virus, a vaccine, an enzyme, or any combination thereof.
  • 22. A method of making the adsorbents of claim 1, said method comprising: contacting the metal oxide particles having a wide pore size distribution as measured by a pore size distribution span 90 value of greater than 2.5 with one or more reactants under reaction conditions that result in the polymeric material covalently bonded to the surfaces of the metal oxide particles, wherein said contacting step utilizes a reaction mixture free of organic solvent.
  • 23. The method of claim 22, wherein the one or more reactants comprise at least one bifunctional compound comprising (i) one or more functional groups capable of bonding the compound to the surfaces of the metal oxide particles, and either (iia) the polymeric material, or (iib) one or more reactive groups capable of bonding to the polymeric material.
  • 24. A method of using adsorbents as defined in claim 1 as a bioprocessing clarification agent, wherein the adsorbents are added to a bioprocessing vessel containing one or more biomolecules, the one or more biomolecules comprising a protein, a polysaccharide, a lipid, a nucleic acid, a metabolites, a mammalian cell, mammalian cell debris, an antibody, a peptide, DNA, RNA, an endotoxin, a virus, a vaccine, an enzyme, or any combination thereof.
  • 25. Adsorbents for use as a bioprocessing clarification agent, said adsorbents comprising: metal oxide particles having a wide pore size distribution as measured by a pore size distribution span 90 value of greater than 2.0; anda cationic polyelectrolyte covalently bonded to surfaces of said metal oxide particles, wherein said cationic polyelectrolyte comprises polyethyleneimine, polyallylamine, polyvinyl pyridine, polydiallyldimethylammonium chloride (pDADMAC), or a copolymer containing one or more cationic or cationic-forming functional groups or the reaction product of said metal oxide particles and an aqueous trimethoxysilyl-polyethyleneimine solution.
  • 26. The adsorbents of claim 25, wherein said metal oxide particles comprise silica particles having (i) a wide pore size distribution as measured by a pore size distribution span 90 value of from about 2.8 to about 7.8, (ii) a BET particle surface area of at least about 100 m2/g up to about 1000 m2/g, and (iii) a pore volume, as measured by mercury intrusion, of from about 1.0 ml/g to about 2.0 ml/g.
  • 27. The adsorbents of claim 26, wherein said cationic polyelectrolyte comprises polyethyleneimine.
  • 28. Adsorbents for use as a bioprocessing clarification agent, said adsorbents comprising: metal oxide particles having a wide pore size distribution as measured by a pore size distribution span 90 value of from about 2.8 to about 7.8; andpolymeric material covalently bonded to surfaces of said metal oxide particles, said polymeric material comprising polyethyleneimine.
  • 29. The adsorbents of claim 28, wherein said metal oxide particles comprise silica particles having (i) a BET particle surface area of at least about 100 m2/g up to about 1000 m2/g, and (ii) a pore volume, as measured by mercury intrusion, of from about 1.0 ml/g to about 2.0 ml/g.
PCT Information
Filing Document Filing Date Country Kind
PCT/US2016/035683 6/3/2016 WO 00
Publishing Document Publishing Date Country Kind
WO2016/196906 12/8/2016 WO A
US Referenced Citations (423)
Number Name Date Kind
3505785 Kirkland Apr 1970 A
3526603 Acker Sep 1970 A
3652216 Krekeler et al. Mar 1972 A
3782075 Kirkland Jan 1974 A
3855172 Iler et al. Dec 1974 A
3869409 Bebris et al. Mar 1975 A
3888972 Kiselev et al. Jun 1975 A
3904598 Isaac Sep 1975 A
3943072 Thomson et al. Mar 1976 A
3956179 Sebestian et al. May 1976 A
3975293 LePage Aug 1976 A
3984349 Meiler et al. Oct 1976 A
4010242 Iler et al. Mar 1977 A
4029583 Ho Chang et al. Jun 1977 A
4034139 Mazarguil et al. Jul 1977 A
4061828 Mazarguil et al. Dec 1977 A
4070286 Iler et al. Jan 1978 A
4076651 Jacques Feb 1978 A
4100149 Meiler et al. Jul 1978 A
4104363 Vozka et al. Aug 1978 A
4118316 Talley et al. Oct 1978 A
4124699 Michel et al. Nov 1978 A
4131542 Bergna et al. Dec 1978 A
4140653 Shirichi et al. Feb 1979 A
4157920 Wason et al. Jun 1979 A
4168216 Burkhardt et al. Sep 1979 A
4170685 Rembaum et al. Oct 1979 A
4199450 Dulout et al. Apr 1980 A
4229342 Mirabel Oct 1980 A
4275300 Abbott Jun 1981 A
4298500 Abbott Nov 1981 A
4308254 Tayot et al. Dec 1981 A
4322542 Abbott Mar 1982 A
4329434 Kimoto et al. May 1982 A
4329435 Kimoto et al. May 1982 A
4376140 Kimoto et al. Mar 1983 A
4397827 Chu Aug 1983 A
4415631 Schutijser Nov 1983 A
4469630 Flashner Sep 1984 A
4496461 Leeke et al. Jan 1985 A
4517131 Hefner, Jr. May 1985 A
4532232 Larsson et al. Jul 1985 A
4536352 Kimoto et al. Aug 1985 A
4540486 Ramsden Sep 1985 A
4551245 Ramsden et al. Nov 1985 A
4560704 Regnier et al. Dec 1985 A
4569917 Maier et al. Feb 1986 A
4576927 Kuroda et al. Mar 1986 A
4581428 Farnham et al. Apr 1986 A
4596660 Hou Jun 1986 A
4597913 Kimoto et al. Jul 1986 A
4606825 Crane et al. Aug 1986 A
4639513 Hou et al. Jan 1987 A
4640909 Ramsden et al. Feb 1987 A
4648975 Barkatt et al. Mar 1987 A
4650784 Ramsden et al. Mar 1987 A
4661248 Ramsden et al. Apr 1987 A
4673734 Tayot et al. Jun 1987 A
4676898 Saxena Jun 1987 A
4699717 Riesner et al. Oct 1987 A
4704374 Jacques Nov 1987 A
4724207 Hou et al. Feb 1988 A
4724210 Oka et al. Feb 1988 A
4732887 Obanawa et al. Mar 1988 A
4740298 Andresen et al. Apr 1988 A
4745097 Maekawa et al. May 1988 A
4746572 Glajch et al. May 1988 A
4756834 Muller et al. Jul 1988 A
4780423 Bluestein et al. Oct 1988 A
4783264 Nylen et al. Nov 1988 A
4851382 Kusano et al. Jul 1989 A
4855054 Williams Aug 1989 A
4895806 Le et al. Jan 1990 A
4917781 Sharifian et al. Apr 1990 A
4923978 McCormick May 1990 A
4950634 Williams et al. Aug 1990 A
4956180 Cassani et al. Sep 1990 A
4959340 Williams Sep 1990 A
4990456 Loucks et al. Feb 1991 A
5004688 Craig et al. Apr 1991 A
5009688 Nakanishi Apr 1991 A
5030286 Crawford et al. Jul 1991 A
5032266 Kirkland et al. Jul 1991 A
5035803 Cohen Jul 1991 A
5057426 Henco et al. Oct 1991 A
5059654 Hou et al. Oct 1991 A
5085779 Crane et al. Feb 1992 A
5087359 Kakodkar et al. Feb 1992 A
5091433 Wulff et al. Feb 1992 A
5092992 Crane et al. Mar 1992 A
5099923 Aften et al. Mar 1992 A
5128291 Wax et al. Jul 1992 A
5141806 Koontz Aug 1992 A
5149425 Mazid Sep 1992 A
5149553 Berg Sep 1992 A
5149646 Crane et al. Sep 1992 A
5151350 Colbert et al. Sep 1992 A
5152906 Aften et al. Oct 1992 A
5190660 Lindoy et al. Mar 1993 A
5190844 Yabuuchi et al. Mar 1993 A
5203991 Kutsuna et al. Apr 1993 A
5230833 Romberger et al. Jul 1993 A
5268097 Girot et al. Dec 1993 A
5318848 Itoh et al. Jun 1994 A
5354548 Araya et al. Oct 1994 A
5372820 Jozefonvicz nee Dorgebray et al. Dec 1994 A
5380706 Himes et al. Jan 1995 A
5401809 Gitzel et al. Mar 1995 A
5431807 Frechet et al. Jul 1995 A
5447859 Prussak Sep 1995 A
5451660 Builder et al. Sep 1995 A
5453186 Muller et al. Sep 1995 A
5468847 Heilmann et al. Nov 1995 A
5480542 Asakawa et al. Jan 1996 A
5510394 Hodgdon Apr 1996 A
5512169 Williams Apr 1996 A
5593576 Girot et al. Jan 1997 A
5593757 Kashiwazaki et al. Jan 1997 A
5610274 Wong Mar 1997 A
5622743 Tanaka et al. Apr 1997 A
5624875 Nakanishi et al. Apr 1997 A
5633290 Frechet et al. May 1997 A
5652348 Burton et al. Jul 1997 A
5674932 Agostini et al. Oct 1997 A
5701956 Hardy et al. Dec 1997 A
5707516 Tomizawa et al. Jan 1998 A
5710264 Urdea et al. Jan 1998 A
5731186 McCaman et al. Mar 1998 A
5759405 Anderson et al. Jun 1998 A
5805264 Janssen et al. Sep 1998 A
5808041 Padhye et al. Sep 1998 A
5856379 Shiratsuchi et al. Jan 1999 A
5861134 Swanson Jan 1999 A
5888397 Rogers et al. Mar 1999 A
5904848 Wong et al. May 1999 A
5906747 Coffman et al. May 1999 A
5911963 Krivak et al. Jun 1999 A
5912037 Michos Jun 1999 A
5914044 Lindoy et al. Jun 1999 A
5922449 Revis Jul 1999 A
5922531 Dubin et al. Jul 1999 A
5945525 Uematsu et al. Aug 1999 A
5948894 Berry et al. Sep 1999 A
5968652 Hanaggi et al. Oct 1999 A
5970915 Schlueter et al. Oct 1999 A
5973068 Yamaya et al. Oct 1999 A
5976479 Alcaraz et al. Nov 1999 A
5993935 Rasmussen et al. Nov 1999 A
6027945 Smith et al. Feb 2000 A
6037465 Hillebrand et al. Mar 2000 A
6043354 Hillebrand et al. Mar 2000 A
6074555 Boos et al. Jun 2000 A
6090288 Berglund et al. Jul 2000 A
6127526 Blank Oct 2000 A
6168773 Sharp Jan 2001 B1
6171486 Green et al. Jan 2001 B1
6204306 Chabrecek et al. Mar 2001 B1
6248911 Canessa et al. Jun 2001 B1
6284470 Bitner et al. Sep 2001 B1
6310199 Smith et al. Oct 2001 B1
6355726 Doemling et al. Mar 2002 B1
6362320 Park et al. Mar 2002 B1
6372353 Karger et al. Apr 2002 B2
6376194 Smith et al. Apr 2002 B2
6379500 Greenwood et al. Apr 2002 B2
6383990 Dawson et al. May 2002 B1
6387974 Deissler et al. May 2002 B1
6426315 Bergstrom et al. Jul 2002 B1
6428707 Berg et al. Aug 2002 B1
6435012 Maikner Aug 2002 B2
6472486 Klaerner et al. Oct 2002 B2
6482324 Kirkland et al. Nov 2002 B2
6488855 Gjerde et al. Dec 2002 B2
6497964 Matsumura et al. Dec 2002 B1
6512060 Matyjaszewski et al. Jan 2003 B1
6537793 Blanche et al. Mar 2003 B2
6555151 Hu et al. Apr 2003 B2
6565905 Ito et al. May 2003 B1
6569910 Spindler et al. May 2003 B1
6596843 Brunelle et al. Jul 2003 B2
6620326 Lihme et al. Sep 2003 B1
6624205 Muranaka Sep 2003 B2
6632848 Sugaya Oct 2003 B2
6649572 Dawson et al. Nov 2003 B2
6797814 Blank Sep 2004 B2
6802966 Wormsbecher Oct 2004 B2
6818259 Koontz Nov 2004 B1
6852009 Kawase et al. Feb 2005 B2
6861103 Chang et al. Mar 2005 B2
6911192 Nakanishi Jun 2005 B2
6916536 Hammen et al. Jul 2005 B1
6949613 Haddleton Sep 2005 B2
6972090 Boschetti et al. Dec 2005 B2
6994791 Muller et al. Feb 2006 B2
6994964 Chang et al. Feb 2006 B1
6998040 Malik et al. Feb 2006 B2
6998042 Wormsbecher Feb 2006 B2
7008542 Belew Mar 2006 B2
7012044 Dawson et al. Mar 2006 B2
7015281 Britsch et al. Mar 2006 B2
7033505 Urano Apr 2006 B2
7067059 Maloisel et al. Jun 2006 B2
7074491 Liu et al. Jul 2006 B2
7078224 Bitner et al. Jul 2006 B1
7125488 Li Oct 2006 B2
7128884 Kirkland et al. Oct 2006 B2
7166213 Wormsbecher Jan 2007 B2
7192560 Parthasarathy et al. Mar 2007 B2
7198855 Liebmann-Vinson et al. Apr 2007 B2
7220703 Hammen et al. May 2007 B2
7229655 Hu et al. Jun 2007 B2
7244568 Goldsborough Jul 2007 B2
7250214 Walter et al. Jul 2007 B2
7250253 Klapproth et al. Jul 2007 B1
7316919 Childs et al. Jan 2008 B2
7318900 DeMarco Jan 2008 B2
7323347 Quinn Jan 2008 B2
7329386 Kobayashi et al. Feb 2008 B2
7332327 Vikholm et al. Feb 2008 B2
7338768 Trau et al. Mar 2008 B1
7374684 Gibson et al. May 2008 B2
7375168 Zhang et al. May 2008 B2
7378479 Tamareselvy et al. May 2008 B2
7390403 Siwak Jun 2008 B2
7396561 Ruhe Jul 2008 B2
7456276 Christensen et al. Nov 2008 B2
7476474 Ganguli et al. Jan 2009 B2
7479223 DiLeo et al. Jan 2009 B2
7482169 Gjerde et al. Jan 2009 B2
7534623 Landers et al. May 2009 B2
7560258 Brueggemeier et al. Jul 2009 B2
7608234 Stenzel et al. Oct 2009 B2
7671203 Antonini Mar 2010 B2
7674835 Rasmussen et al. Mar 2010 B2
7683011 Putzig Mar 2010 B2
7692013 Antonini Apr 2010 B2
7714112 Engstrand et al. May 2010 B2
7732383 Putzig Jun 2010 B2
7736612 Kubota Jun 2010 B2
7745582 Lihme et al. Jun 2010 B2
7754660 Putzig Jul 2010 B2
RE41595 Shandle et al. Aug 2010 E
7767399 Murphy et al. Aug 2010 B2
7780946 Wormsbecher Aug 2010 B2
7790657 Putzig Sep 2010 B2
7795189 Putzig Sep 2010 B2
7795190 Putzig Sep 2010 B2
7824548 DiLeo Nov 2010 B2
7851417 Putzig Dec 2010 B2
7867738 Dicosimo et al. Jan 2011 B2
7875317 Nakagawa et al. Jan 2011 B2
7897051 Sohling et al. Mar 2011 B2
7919177 Jiang et al. Apr 2011 B2
7922908 Allington et al. Apr 2011 B2
7943046 Martosella et al. May 2011 B2
7960311 Carlson Jun 2011 B2
7994092 Gorkovenko et al. Aug 2011 B2
8197782 DeVera Jun 2012 B2
8242050 Lu et al. Aug 2012 B2
8481298 Andersson et al. Jul 2013 B2
8551894 Seshadri et al. Oct 2013 B2
8658277 Wyndham et al. Feb 2014 B2
8673988 Graalfs et al. Mar 2014 B2
8791220 Jiang et al. Jul 2014 B2
9556258 Nti-Gyabaah Jan 2017 B2
20020006493 Chabrecek et al. Jan 2002 A1
20020012982 Blakesley et al. Jan 2002 A1
20020028520 Boschetti et al. Mar 2002 A1
20020043499 Hammen et al. Apr 2002 A1
20020099104 Muranaka et al. Jul 2002 A1
20020127587 Simms et al. Sep 2002 A1
20020166816 Allen et al. Nov 2002 A1
20030017464 Pohl Jan 2003 A1
20030075508 Woodruff et al. Apr 2003 A1
20030108879 Klaerner et al. Jun 2003 A1
20030171443 Erbacher Sep 2003 A1
20030187227 Lihme et al. Oct 2003 A1
20030201229 Siwak et al. Oct 2003 A1
20030225261 Taylor et al. Dec 2003 A1
20040028901 Rumpf et al. Feb 2004 A1
20040053355 Wainer Mar 2004 A1
20040058059 Linford et al. Mar 2004 A1
20040091411 Modrek-Najafabadi May 2004 A1
20040127648 Guerrer et al. Jul 2004 A1
20040159611 Urano Aug 2004 A1
20040203308 Ko et al. Oct 2004 A1
20040211724 Gibson et al. Oct 2004 A1
20040224843 Hammen et al. Nov 2004 A1
20040266896 Britsch et al. Dec 2004 A1
20050029196 Rhemrev-Boom Feb 2005 A1
20050032922 Deorkar Feb 2005 A1
20050100905 Nassoy et al. May 2005 A1
20050106602 Akhavan-Tafti May 2005 A1
20050115903 Hallier-Soulier et al. Jun 2005 A1
20050158837 Bond Jul 2005 A1
20050200025 Casey et al. Sep 2005 A1
20050269257 Voute et al. Dec 2005 A1
20050282294 Britsch Dec 2005 A1
20060035224 Johansen Feb 2006 A1
20060041035 Poppe et al. Feb 2006 A1
20060058181 Margetts Mar 2006 A1
20060105391 Engel et al. May 2006 A1
20060120683 Kamp et al. Jun 2006 A1
20060144770 Granger et al. Jul 2006 A1
20060147344 Ahn et al. Jul 2006 A1
20060180549 Liu et al. Aug 2006 A1
20060240633 Martosella et al. Oct 2006 A1
20070112178 Johansson et al. May 2007 A1
20070135304 Walter et al. Jun 2007 A1
20070141325 O'Gara et al. Jun 2007 A1
20070178465 Sudor et al. Aug 2007 A1
20070181482 Abudokirim et al. Aug 2007 A1
20070193954 Busson Aug 2007 A1
20070215547 O'Gara Sep 2007 A1
20070276131 Ferre et al. Nov 2007 A1
20080017579 Hermansson et al. Jan 2008 A1
20080025900 Mori Jan 2008 A1
20080026486 Cooper et al. Jan 2008 A1
20080033103 Kameda et al. Feb 2008 A1
20080038750 Piehler et al. Feb 2008 A1
20080053908 Chordia et al. Mar 2008 A1
20080071003 Sellergren et al. Mar 2008 A1
20080116122 Wheelwright et al. May 2008 A1
20080146454 Cuppoletti et al. Jun 2008 A1
20080153100 Rank et al. Jun 2008 A1
20080154029 Balayan et al. Jun 2008 A1
20080164211 Lindner et al. Jul 2008 A1
20080210615 Joehnck et al. Sep 2008 A1
20080213906 Aurand et al. Sep 2008 A1
20080223794 Yamamichi et al. Sep 2008 A1
20080236824 Putzig Oct 2008 A1
20080249326 Nakajima et al. Oct 2008 A1
20080269368 Wyndham et al. Oct 2008 A1
20080269475 Sohling Oct 2008 A1
20080277346 Kirkland et al. Nov 2008 A1
20080293959 Liu et al. Nov 2008 A1
20080311681 Johannsen et al. Dec 2008 A1
20090035876 Williams et al. Feb 2009 A1
20090048433 Richter et al. Feb 2009 A1
20090048439 Weisburg et al. Feb 2009 A1
20090056541 Davison et al. Mar 2009 A1
20090062519 Okamoto et al. Mar 2009 A1
20090074709 Koepsel et al. Mar 2009 A1
20090127501 Kashima et al. May 2009 A1
20090151946 Putzig Jun 2009 A1
20090151947 Putzig Jun 2009 A1
20090170973 Mattiasson et al. Jul 2009 A1
20090186093 Liu et al. Jul 2009 A1
20090192342 Coupard et al. Jul 2009 A1
20090197332 Andreou et al. Aug 2009 A1
20090206034 Nakajima Aug 2009 A1
20090211453 Nassivera et al. Aug 2009 A1
20090221809 Sohling et al. Sep 2009 A1
20090232950 Brothers, Jr. et al. Sep 2009 A1
20090246885 Bian et al. Oct 2009 A1
20090277838 Liu et al. Nov 2009 A1
20090294362 Persson et al. Dec 2009 A1
20090297853 Kirkland et al. Dec 2009 A1
20090306292 Bendejacq et al. Dec 2009 A1
20090308599 Dusterhoft et al. Dec 2009 A1
20090308811 Tepper et al. Dec 2009 A1
20100022419 Reed et al. Jan 2010 A1
20100029794 Yilmaz et al. Feb 2010 A1
20100055667 Hage et al. Mar 2010 A1
20100075404 Templeton Mar 2010 A1
20100099579 Chilkoti et al. Apr 2010 A1
20100116743 Pryor et al. May 2010 A1
20100129830 Deshayes et al. May 2010 A1
20100132251 Sohling et al. Jun 2010 A1
20100156135 Farokhzad et al. Jun 2010 A1
20100159254 Oertli et al. Jun 2010 A1
20100181254 Graalfs Jul 2010 A1
20100237019 Aldegonda et al. Sep 2010 A1
20100255310 Chen Oct 2010 A1
20100272996 Homes et al. Oct 2010 A1
20100310539 Garcia-Bennett Dec 2010 A1
20100310865 Kumar et al. Dec 2010 A1
20110017670 Anderson Jan 2011 A1
20110049042 DiLeo et al. Mar 2011 A1
20110049056 Wyndham et al. Mar 2011 A1
20110059845 Fryxell Mar 2011 A1
20110065901 Soice et al. Mar 2011 A1
20110100915 Kanda et al. May 2011 A1
20110121229 Linder et al. May 2011 A1
20110139717 Malenfant et al. Jun 2011 A1
20110160104 Wu et al. Jun 2011 A1
20110162153 Niembro et al. Jul 2011 A1
20110184154 Zarbis-Papastoitsis et al. Jul 2011 A1
20110186519 Balayan et al. Aug 2011 A1
20110201078 Rasmussen et al. Aug 2011 A1
20110245077 Anderson et al. Oct 2011 A1
20110284465 Liu et al. Nov 2011 A1
20110313147 Boschetti et al. Dec 2011 A1
20110313712 Nikolyn et al. Dec 2011 A1
20120024791 Deetz et al. Feb 2012 A1
20120055860 Wyndham Mar 2012 A1
20120065393 Choi et al. Mar 2012 A1
20120071643 Helfer et al. Mar 2012 A1
20120108803 Han et al. May 2012 A1
20120205315 Liu et al. Aug 2012 A1
20120231537 Templeton Sep 2012 A1
20120259094 Hearn et al. Oct 2012 A1
20120283337 Brick et al. Nov 2012 A1
20130020523 Han et al. Jan 2013 A1
20130041135 Tamori et al. Feb 2013 A1
20130046056 Spector et al. Feb 2013 A1
20130056415 Kozlov et al. Mar 2013 A1
20130109072 Tsunoda et al. May 2013 A1
20130112623 Fernandez-Lahore et al. May 2013 A1
20130122215 Waller et al. May 2013 A1
20130131321 Bittermann et al. May 2013 A1
20130133516 Okano et al. May 2013 A1
20130146542 Huang et al. Jun 2013 A1
20130178608 Kulkarni et al. Jul 2013 A1
20130189322 Honeyman et al. Jul 2013 A1
20130193052 Witt et al. Aug 2013 A1
20130245139 Kozlov et al. Sep 2013 A1
20130274451 Bjorkman et al. Oct 2013 A1
20130313187 Yin et al. Nov 2013 A1
20140046023 Gottschall et al. Feb 2014 A1
20140046029 Shannon et al. Feb 2014 A1
20140093888 Templeton Apr 2014 A1
20140367338 Gu et al. Dec 2014 A1
Foreign Referenced Citations (87)
Number Date Country
1303594 Jun 1992 CA
2564413 Dec 2005 CA
101381437 May 2011 CN
102443120 Mar 2013 CN
102675564 Apr 2014 CN
102006012467 Sep 2007 DE
0172579 Feb 1986 EP
0106769 Jan 1987 EP
0263934 Apr 1988 EP
0239079 Jul 1988 EP
0403700 Aug 1992 EP
0545677 Jun 1993 EP
0300273 Mar 1994 EP
0463036 Feb 1995 EP
0520109 Mar 1995 EP
0490300 Mar 1998 EP
0950067 Oct 1999 EP
1229094 Aug 2002 EP
1758671 Mar 2007 EP
1864999 Dec 2007 EP
1897890 Mar 2008 EP
1900751 Mar 2008 EP
2217646 Aug 2010 EP
2352771 Aug 2011 EP
2616169 Jul 2013 EP
S5226386 Feb 1977 JP
59050052 Mar 1984 JP
59050054 Mar 1984 JP
S6486868 Mar 1989 JP
H02142798 May 1990 JP
06016738 Jan 1994 JP
8134138 May 1996 JP
2001521507 Nov 2001 JP
2003526796 Sep 2003 JP
2008012460 Jan 2008 JP
2009126948 Jun 2009 JP
2011001336 Jan 2011 JP
2011523624 Aug 2011 JP
2012012334 Jan 2012 JP
2012042477 Mar 2012 JP
2012086221 May 2012 JP
2012139678 Jul 2012 JP
2013510918 Mar 2013 JP
8303776 Nov 1983 WO
1992002638 Feb 1992 WO
9400237 Jan 1994 WO
9403268 Feb 1994 WO
1994012526 Jun 1994 WO
9525789 Sep 1995 WO
1996034883 Nov 1996 WO
9705174 Feb 1997 WO
9831461 Jul 1998 WO
1998058072 Dec 1998 WO
0102452 Jan 2001 WO
0188520 Nov 2001 WO
0228912 Apr 2002 WO
2002074791 Sep 2002 WO
03031580 Apr 2003 WO
03049671 Jun 2003 WO
2003102184 Dec 2003 WO
2004009677 Jan 2004 WO
2004015120 Feb 2004 WO
2004024318 Mar 2004 WO
2004076511 Sep 2004 WO
2006110314 Oct 2006 WO
2008027262 Mar 2008 WO
2008140652 Nov 2008 WO
2008147717 Dec 2008 WO
2009053317 Apr 2009 WO
2009079325 Jun 2009 WO
2009102207 Aug 2009 WO
2009150402 Dec 2009 WO
2010027955 Mar 2010 WO
2010043700 Apr 2010 WO
2010043701 Apr 2010 WO
2010043703 Apr 2010 WO
2011012302 Feb 2011 WO
2011025867 Mar 2011 WO
2011107299 Sep 2011 WO
2012087231 Jun 2012 WO
2013004587 Jan 2013 WO
2013007793 Jan 2013 WO
2013062105 May 2013 WO
2013089477 Jun 2013 WO
2014058570 Apr 2014 WO
2014090838 Jun 2014 WO
2014094957 Jun 2014 WO
Non-Patent Literature Citations (74)
Entry
Azizi, Najmodin; Saidi, Mohammad, “Highly Chemoselective Addition of Amines to Epoxides in Water”, Organic Letters, v 7, n 17, p. 3649-3651 (2005).
Buncek, M.; Backovska, V.; Holasova, S.; Radilova, H.; Safarova, M.; Kunc, F.; Haluza, R., “Unusual Chromatographic Behavior of Oligonucleotide Sequence Isomers on Two Different Anion Exchange HPLC Columns”, Analytical Biochemistry, n 348, p. 300-306 (2006).
Chen, Feng; Wan, Decheng; Chang, Zhihong; Pu, Hongting; Jin, Ming, “Highly Efficient Separation, Enrichment, and Recovery of Peptides by Silica-Supported Polyethylenimine”, Langmuir, n 30, p. 12250-12257 (2014).
Dib, Samia; Faria, Anizio, “Polyethyleneimine Immobilized on Silica Endcapped with Octadecyl Groups as a Stationary Phase for RP-LC”, Chromatographia, n 77, p. 533-541 (2014).
Flashner, Michael; Ramsden, Hugh; Crane, Laura, “Separation of Proteins by High-Performance Anion-Exchange Chromatography”, Analytical Biochemistry, n 135, p. 340-344 (1983).
Gu, Feng; Chodavarapu, Kiran; McCreary, Dennis; Plitt, Thomas; Tamoria, Edward; Ni, Michelle; Burnham, Jennifer; Peters, Michael, Lenhoff; Abraham, “Silica-Based Strong Anion Exchange Media for Protein Purification”, Journal of Chromatography A, n 1376, p. 53-63 (2015).
Kang, Xuezhen; Bates, Ronald; Frey, Douglas, “High-Performance Chromatofocusing Using Linear and Concave pH Gradients Formed with Simple Buffer Mixtures II. Separation of Proteins”, Journal of Chromatography A, n 890, p. 37-43 (2000).
Minow, Benjamin; Egner, Florian; Jonas, Franziska; Lagrange, Bertille, “High-Cell Density Clarification by Single-Use Diatomaceous Earth Filtration”, BioProcess International, n 12, v 4, supplement (2014).
Schirmer, Emily; Kuczewski, Michael; Golden, Kathryn; Lain, Blanca; Bragg, Carissa; Chon, John; Cacciuttolo, Marco; Zarbis-Papastoitsis, Gregory, “Primary Clarification of Very High-Density Cell Culture Harvests by Enhanced Cell Settling”, BioProcess International, p. 32-39 (2010).
PCT Search Report and Written Opinion for PCT/US2016/035683; dated Sep. 2, 2016.
Bach, Long Giang; Islam, Md. Rafiqul; Jeong, Yean Tae; Hwang, Ha Sao; Lim, Kwon Taek, “A Facile Synthesis of PMMA-Si02 Nanocomposites via Surface Initiated Radical Polymerization”, Molecular Crystals and Liquid Crystals, 565(1), 78-87 (2012).
Banerjee, Jaya; Kumar, Rajesh; Srivastava, Abhishek; Behari, Kunj, “Graft Copolymerization of 2-Acrylamido-2-Methyl-1-Propanesulfonic Acid onto Carboxymethylcellulose (Sodium Salt) Using Bromate/Thiourea Redox Pair”, Journal of Applied Polymer Science, 100(1), 26-34 (2006).
Binghe Gu, Yun Li and Lee, Milton L., “Polymer Monoliths with Low Hydrophobicity for Strong Cation-Exchange Capillary Liquid Chromatography of Peptides and Proteins”, Analytical Chemistry, v 79, n 15, p. 5848-5855 (2007).
Bowes, Brian D., “Protein Transport and Adsorption in Polymer-Modified Ion-Exchange Media”, University of Delaware, ProQuest Dissertations Publishing (2011).
Boyle, M.D.P., Reis, K.J. “Bacterial Fc Receptors”, Nature Biotechnology 5, p. 697-703 (1987).
Breadmore, Michael C.; Shrinivasan, Sushil; Karlinsey, James; Ferrance, Jerome P.; Norris, Pamela M.; Landers, James P. “Towards a Microchip-Based Chromatographic Platform. Part 2: Sol-Gel Phases Modified with Polyelectrolyte Multilayers for Capillary Electrochromatography”, Electrophoresis, v 24, p. 1261-1270 (2003).
Brunauer, Stephen, Emmett, P.H., Teller, Edward “Adsorption of Gases in Multimolecular Layers” Journal of American Chemical Soceity, 60, p. 309-319 (1938).
Bruno, G.; Gasparrini, F.; Misiti, D.; Arrigoni-Martelll. E.; Bronzetti, M. “High-performance liquid chromatographic separation of biomolecules using calcium phosphate supported on macroporous silica microparticles”, Journal of Chromatography, v 504, n 2, p. 319-333, 19g0; ISSN: 00219673, Publisher: Elsevier.
Buess-Herman, Claudine et al. “Hydration of a Polysulfone Anion-Exchange Membrane Studied by Vibrational Spectroscopy,” Langmuir, vol. 19, No. 8 (2003).
Capito, Florian; Bauer, Johann: Rapp, Almut; Schroter, Christian; Kalmar, Harald; Stanislawski, Bernd, “Feasibility Study of Semi-Selective Protein Precipitation with Salt-Tolerant Copolymers for Industrial Purification of Therapeutic Antibodies”, Biotechnology and Bioengineering, v 110, n 11, p. 2915-2927 (2013).
Carrot, Geraldine; Perez, Henri, “Controlled Surface Initiated Polymerizations from Inorganic Nanoparticles”, Polymer Preprints (American Chemical Society, Division of Polymer Chemistry), 47(2), 827-828 (2006).
Chen, Xin; Tolley, H. Dennis; Lee, Milton L., “Polymeric Cation-Exchange Monolithic Columns Containing Phosphoric Acid Functional Groups for Capillary Liquid Chromatography of Peptides and Proteins”, Journal of Chromatography A, v 1217, n 24, p. 3844-3854 (2010).
Dhar, P.; Vatansever. F.; Seery, “Modification of Silica Surfaces Using Surface Initiated Polymerization”, Book of Abstracts, 215th ACS National Meeting, Dallas, Mar. 29-Apr. 2, PMSE-147 (1998).
Dyer, Daniel J.; Zhao, Tongfeng; Green, John-Bruce, “Surface Initiated Photopolymerization from Gold”, Polymer Preprints (American Chemical Society, Division of Polymer Chemistry), 42(2) (2001).
Emara, Samy; Masujima, Tsutomu; Hadad, Ghada: Kamal, Maha; Zaazaa, Hala; Kawi, Mohamed Abdel, “A Rapid, Sensitive, and Environmentally Friendly On-Line Solid Phase Extraction Using Protein-Coated IJ-Bondapak Cyanide Silica Precolumn for Chromatographic Determination of Paracetamol in Human Serum.”, Journal of Liquid Chromatography and Related Technologies, v 36, n 10, p. 1297-1311, Apr. 1, 2013; ISSN: 10826076, E-ISSN: 1520572X; DOI: 10, 1080/10826076.2012,686139; Publisher: Taylor and Francis Inc.
Guo, Hui, “Development of Chromatofocusing Techniques Employing Mixed-Mode Column Packings for Biomolecule Separations”, Dissertations & Theses, University of Maryland, Baltimore County, ProQuest, UMI Dissertations Publishing (2014).
Hatch, R.G., “Chromatography of Proteins on a Silica-Based Support with Polyethylene No Glycol ligands”, Journal of Chromatographic Science, v 28, n 4, p. 210-214, Apr. 1990; ISSN: 00219665.
Hernstrom, Petrus et al. “Atom-Transfer Radical Graft Polymerization Initiated Directly from Silica Applied to Functionalization of Stationary Phases for High-Performance Liquid Chromatography in the Hydrophilic Interaction Chromatography Mode,” Analytical Chemistry, 78 (2006), pp. 7098-7103.
Huang, Meiyu; Wu, Ru, “Polymerization of Acrylic Acid Initiated by Poly(y-mercaptopropylsiloxane-lanthanide) Complexes”, Ziran Zazhi, 5(12), 950-1 (1982).
Jandera, Pavel, “Stationary phases for hydrophilic interaction chromatography, their characterization and implementation into multidimensional chromatography concepts.” Journal of Separation Science, v 31, n 9, pp. 1421-1437, May 2008, Hydrophilic interaction chromatography; ISSN: 16159306, E-ISSN: 16159314; DOI: 10.1002/jssc.200800051, Publisher: Wiley-VCH Verlag.
Katoh, Shigeo et al. “Affinity Purification of Antibodies: Optimization Strategies of Protein A-Coupled Silica Media”, G.I.T. Laboratory Journal May-Jun. 2007 p. 26-27.
Katoh, Shigeo, “Affinity chromatography for large-scale purification of antibody pharmaceuticals”, Biotechnology-based drug manufacturing technology series. Pharm Tech Japan, v 27, No. 11, 2011.
Katoh, Shigeo; Imada, Masami; Takeda, Naoki; Katsuda, Tomohlsa; Miyahara, Hiroyoshi; Inoue, Masaki; Nakamura, Shuji, “Optimization of silica-based media for antibody purification by protein A affinity chromatography”, Journal of Chromatography A, v 1161, n 1-2, p. 36-40, Aug. 17, 2007, 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotfdes; ISSN: 00219673; DOI: 10.1016/j.chroma.2007,04.023; Publisher: Elsevier.
Kuroda, Hirofumi; Nakatsuchi, Sayaka; Kitao, Nobuyoshi; Nakagawa, Tsuyoshi; “Radical polymerization of Methacrylates Having Moiety Activated by Electron-Withdrawing Group as a Reactive Functional Group” Relative & Functional Polymers, v 66, p. 229-238 (2006).
Liu, Shu-juan; Dun, Hui-juan; Zhou, Feng; Zhao, Liang; Liu, Xia; Jiang, Sheng-xiang, “Preparation of Polymer Modified Stationary Phases through Surface Radical Chain Transfer Reaction” Sepu, 20(5), 432-435 (2002).
Liu, Shu-juan; Zhou, Feng; Jiang, Sheng-xiang; Liu, Wei-min, “Characterization of Polymer Brushes on Nanoparticle Surfaces” Gaofenzi Cailiao Kexue Yu Gongcheng, 19(6), 65-68 (2003).
Liu, Shu-juan; Zhou, Feng; Jiang, Sheng-xiang; Liu, Wei-min, “Preparation of Stationary Phase for HPLC Through Surface-Initiated Polymerization” Gaofenzi Cailiao Kexue Yu Gongcheng, 19(6), 65-68 (2003).
Ma, Z et al. “Synthesis of Magnetic Chelator for High-Capacity Immobilized Metal Affinity Adsorption of Protein by Cerium Initiated Graft Polymerization.” Langmuir, vol. 21, No. 15 (2005).
Maiti, Sukumar; Palit, Santi “Thiols as Redox Initiator for Vinyl Polymerization” Journal of Polymer Science: Polymer Chemistry, v 9, n 1, p. 253-256 (1971).
Manda, Keerthini “Synthesis and characterization of protein bonded stationary phases for HPAC.”, Source: Dissertations & Theses, 2007. vol. 46, Issue 1, Publication I order No. AAI1445247; http://search.proquest.com/docviewf33934537?accountid=142944.
Massom, L R; Ulbright, C; Snodgrass, P; Jarrett, H W, “Protein A-silica: Purification of Antibodies and Antigen/Antibody Complexes by High Pressure Affinity Chromatography”, Biochromatography 4.3 (1989): 144-148; http://search. proquest.com/docview/15419101?accountid=142944.
McCue, Justin T.; Kemp, Glen; Low, Duncan; Quiniones-Garcia, Igor, “Evaluation of protein-A chromatography media”, Science Direct_Journal of Chromatography A, 989 (2003) 139-153.
Mihai, M.; Schwarz, S.; Janke, A; Ghiorghia, C.A.; Dragan, E.S., “Silica Microparticles Surface Coating by Layer-by-Layer or Polyelectrolyte Complex Adsorption”, Periodical: Journal of Polymer Research, v 20, n 2, 89 (2013).
Min, Jun Ho; Min, Seong Kee, “The Characteristics of Poly(acrylamide)-SiOx Nanoparticles Prepared by Graft-Polymerization”, Periodical: Kongop Hwahak, 21(1), 34-39 (2010).
Miyahara, H; Nakashima, R; Inoue, M; Katsuda, T; Yamaji, H. Katoh, S; “Optimization and Performance of Silica-Based Media for Industrial-Scale Antibody Purification” Chemical Engineering & Technology (2012), 35, No. 1, 157-160. Publisher. Wiley-VCH Verlag.
Moon, Jung-Min et al. “Modification of Monodisperse Colloidal Silica by Radical Copolymerization of Cationic Surface Active Vinyl Monomers,” Polymer Journal, vol. 41, No. 3 (2009), pp. 208-213.
Mori, Hideharu et al. “Controlled Radical Polymerization of an Acrylamide Containing I-Phenylalanine Moiety via RAFT.” Macromolecules, No. 38, p. 9055-9065 (2005).
Murofushi, Katsumi, “Additive for Increase in Hardness and Adhesiveness of Photocurable Resin”, Periodical: Purasuchikkusu, 57(9), 37-40 (2006).
Narayanan, S.; CraneS., “Affinity Chromatography Supports: A Look at Performance Requirements”, Trends in Biotechnology, vol. 8, 1990, pp. 12-16; DOI: 10.1016/0167-7799(90)90124-G; Publisher: Elsevier.
Ohlson S, Wieslander J, “High-Performance Liquid Affinity Chromatographic Separation of Mouse Monoclonal Antibodies with Protein a Silica.”, J Chromatogr. Jun. 26, 1987;397:207-12; Publisher: Elsevier.
Okaya, Takuji; Kikuchi, Kanji; Morii, Yukiko “Polymerization of Acrylamide in Aqueous Medium Initiated with a Redox System Composed of Cysteine and Potassium Bromate” Macromolecular Chemistry and Physics, v 198, p. 2027-2034 (1997).
Park, Mi⋅kyoung; Sakellariou, George; Pispas, Stergios; Hadjichristides, Nikos; Mays, Jimmy; Advincula, Rigoberto, “Living Anionic Surface Initiated Polymerization (LASIP): Synthesis and Characterization of Block Copolymers”, Periodical: Abstracts of Papers, 223rd ACS National Meeting, Orlando, FL, United States, Apr. 7-11, 2002.
Prucker, Oswald; Habicht, Jorg; Park, In-Jun; Ruhe, Jurgen, “Photochemical Strategies for the Preparation, Micropatterning and Modification of Polymer Brushes”, Periodical: Polymer Preprints (American Chemical Society, Division of Polymer Chemistry), 44(1), 470-471 (2003).
Rashid, Harun-Or; Lee, Won-Ki; Hong, Seong-Soo; Park, Jong Myung; Kim, Hyun Gyu; Um, Kwon Taek “Polymer Brushes on Carbon Nanotubes by Thioi-Lactam Initiated Radical Polymerization of 2-Hydroxyethyl Methacrylate”, Journal of Nanoscience and Nanotechnology, v 12, p. 840-846 (2012).
Roy, Asit; Roy, Sujata, “Preparation of a high flow packing material (silica based) for high performance affinity chromatography of proteins.” Affinity Chromatography and Biological Recognition, 1983, AMF Speciality Materials Group Meriden, Connecticut, USA, ISBN 0-12-166580-1. Publisher: Academic Press, Inc.
Salarizadeh, Parisa; Javanbakht. Mehran; Abdollahi, Mandi; Naji, Leila, “Preparation, Characterization and Properties of Proton Exchange Nanocomposite Membranes Based on Poly(Vinyl Alcohol) and Poly(Sulfonic Acid)-Grafted Silica Nanoparticles” International Journal of Hydrogen Energy, v 38, n 13 (2013).
Savina, Irina et al. “Anion-Exchange Supermacroporous Monolithic Matrices with Grafted Polymer Brushes of N,N-Dirnethylaminoethyi-Methacrylate,” Journal of Chromatography A, vol. 1092, No. 2 (2005).
Savina, Irina et al. “ion-Exchange Macroporous Hydrophilic Gel Monolith with Grafted Polymer Brushes.” J. Mol. Recognit., vol. 19, No. 4 (2006).
Schmidt, D.E.; Giese, R.W.; Conran, D.; Karger, B.L, “High performance liquid chromatography of proteins on a dial-bonded silica gel stationary phase”, Analytical Chemistry, v 52, n 1, 177-82, Jan. 1980; ISSN: 0003-2700; Country of publication: USA. Publisher. American Chemical Society.
Shimomura, Masato; Kikuchi, Hiroaki; Matsumoto, Hiroshi; Yamauchi, Takeshi; Miyauchi, Shinnosuke “Attaching of Poly(acrylic acid) to Inorganic Surface and its Application to Enzyme Immobilization” Polymer Journal, v 27, n 9, p. 974-977 (1995).
Shukla, J.S.; Singh, Khajan “Aqueous Polymerization of Acrylamide”, Journal of Polymer Science: Polymer Chemistry Edition, vol. 17, 531-538 (1979).
Srivastava, Arti; Behari, Kunj, “Graft Copolymerization of 2-Acrylamido-2-Methyi-1-Propane Sulphonic Acid onto Xanthan Gum by Ascorbic / Bromate Redox Pair” PMSE Preprints, 90, 698-699 (2004).
Tessrkmen, Deniz et al. “Synthesis of Tentacle-Type Magnetic Beads as Immobilized Metal-Chelate Affinity Support for Cytochrome C Adsorption,” Int. J. Bioi. Macromol., vol. 38, No. 2 (2006).
Tsuneda, Setal. “Biding of Lysozyme onto a Cation-Exchange Microporous Membrane Containing Tentacle-Type Grafted Polymer Branches,” Biotechnol Prog., vol. 10, No. 1 (1994).
Vuignier, Kanne; Fekete, Szabolcs; Carrupt, Pierre-Aiain; Veuthey, Jean-Luc; Guillarme, Davy, “Comparison of Various Silica-Based Monoliths for the Analysis of Large Biomolecules”, Journal of Separation Science, v 36, n 14, p. 2231-2243, Jul. 2013; ISSN: 16159306, E-ISSN: 16159314; DOI: 10.1002/jssc.201300323; Publisher: Wiley.VCH Verlag.
Wang, Xiao-hua; Gao, Bao-jlao; Wang, Ming-juan; Fang, Xiao-lin, “Realizing Highly Effective Graft-Polymerization of Acrylonitrile on Surfaces of Silica Gel Particles by Constructing Mercapto Group-Cerium (IV) Salt Redox Initiation System” Gaofenzi Xuebao, (3), 256-263 (2012).
Wei, Bingchuan, “Silica colloidal crystals for ultra-efficient protein separations”, Dissertations & Theses, Purdue University, ProQuest, UMI Dissertations Publishing, 2011. 3506193; ISBN 9781267315243; http://search.proquest.com/docview/1014174524?accountid=142944, Publisher. UMI Dissertations Publishing 2011.
Xu, Liang et al. “Fabrication and Characterization of Open-Tubular CEC Modified with Tentacle-Type Metal Chelating Polymer Chains,” Electrophoresis, vol. 28, No. 11 (2007).
Xu, Liang et al. “Novel Negatively Charged Tentacle-Type Polymer Coating for On-Line Preconcentration of Proteins in CE.” Electrophoresis, vol. 30, No. 4 (2009).
Xu, Liang et al. “Novel Open Tubular CEC with Tentacle-Type Polymer Stationary Phase Functionalized by Phenylalanine.” Electrophoresis, vol. 29, No. 4 (2008).
Yanase, Tomohiro et al. “Regeneration Technology of Tetramethylammonium Hydroxide Using ton Exchange Resin.” Technology Reports of Kansai University, No. 47 (2005).
Yoshinaga, Kohji; Kondo, Akihiko; Higashitani, Ko; Kito, Taketoshi, “Immobilization of Protein on Monodispersed Colloidal Silica with Poly(Ethylene Glycol) Spacer and Application of the Composites to Immunological Agglutination Tests”, Colloids and Surfaces A: Physicochemical and Engineering Aspects, v 77, n 2, p. 101-107, Sep. 17, 1993; ISSN: 09277757; DOI: 10.1 016/0927-7757(93)80106-0.
Zhang, Jian et al. “Capillary Electrochromatography of Peptides on a Column Packed with Tentacular Weak Cation-Exchanger Particles,” Journal of Chromatography A, 953 (2002), pp. 239-249.
Zhang, Wenjun; Hu, Baoan; Zhang, Yan; Su, Hui; Xiao, Min, “Preparation of Novel Amphiphilic Polymeric Flocculant by Dispersion Polymerization Method”, Huaxue Gongcheng, 37(2), 67-70 (2009).
Related Publications (1)
Number Date Country
20180169610 A1 Jun 2018 US
Provisional Applications (1)
Number Date Country
62171669 Jun 2015 US